Metastatic disease of the skeleton

American Family Physician

Volumn 55, Issue 5, 1997, Pages 1761-1768

  Buckwalter, Joseph A ^a   Brandser, Eric A ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; STRONTIUM 89;

BONE BIOPSY; BONE METASTASIS; BONE PAIN; BONE RADIOGRAPHY; BONE SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGIC FRACTURE; REVIEW;

EID: 0030975627     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Rasmusson B, Vejborg I, Jensen AB, Andersson M, Banning AM, Hoffmann T, et al. Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up. Radiother Oncol 1995; 34:179-84.
2. Chigira M, Shinozaki T. Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas. Arch Orthop Trauma Surg 1990;109:247-51.
3. Algra PR, Bloem JL, Tissing H, Falke TH, Arndt JW, Verboom LJ. Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographics 1991;11:219-32.
4. Schaffer DL, Pendergrass HP. Comparison of enzyme, clinical, radiographic, and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology 1976;121:431-4.
5. Yoshida K, Akimoto M. Computed tomographic evaluation of bone metastases in prostatic cancer patients. Adv Exp Med Biol 1992;324:197-204.
6. Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am 1993; 75:1276-81.
7. Sanal SM, Flickinger FW, Caudell MJ, Sherry RM. Detection of bone marrow involvement in breast cancer with magnetic resonance imaging. J Clin Oncol 1994;12:1415-21.
8. Shih LY, Chen TH, Lo WH. Skeletal metastasis from occult carcinoma. J Surg Oncol 1992;51:109-13.
9. Twycross RG. Management of pain in skeletal metastases. Clin Orthop 1995;312:187-96.
10. Houston SJ, Rubens RD. The systemic treatment of bone metastases. Clin Orthop 1995;312:95-104.
11. Kanis JA, McCloskey EV, Taube T, O'Rourke N. Rationale for the use of bisphosphonates in bone metastases. Bone 1991;12(Suppl 1):13-8.
12. Dijstra S, Wiggers T, van Geel BN, Boxma H. Impending and actual pathological fractures in patients with bone metastases of the long bones. A retrospective study of 233 surgically treated fractures. Eur J Surg 1994;160:535-42.
13. Hansen DV, Holmes ER, Catton G, Thorne DA, Chadwick DH, Schmutz DA. Strontium-89 therapy for painful osseous metastatic prostate and breast cancer. Am Fam Physician 1993;47:1795-800.